Centrum Medyczne ENEL-MED Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Centrum Medyczne ENEL-MED.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Healthcare winstgroei | 21.5% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Recent updates
Centrum Medyczne ENEL-MED's (WSE:ENE) Solid Earnings Are Supported By Other Strong Factors
May 30
Calculating The Fair Value Of Centrum Medyczne ENEL-MED S.A. (WSE:ENE)
Apr 21Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital Not Reflecting Well On The Business
May 12Is Centrum Medyczne ENEL-MED (WSE:ENE) A Risky Investment?
Jun 09Is There More Growth In Store For Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital?
Feb 22We Think Centrum Medyczne ENEL-MED (WSE:ENE) Can Stay On Top Of Its Debt
Feb 01We Think Centrum Medyczne ENEL-MED's (WSE:ENE) Statutory Profit Might Understate Its Earnings Potential
Jan 11
Can Mixed Fundamentals Have A Negative Impact on Centrum Medyczne ENEL-MED S.A. (WSE:ENE) Current Share Price Momentum?
Dec 21Does Centrum Medyczne ENEL-MED's (WSE:ENE) Share Price Gain of 92% Match Its Business Performance?
Nov 30In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Centrum Medyczne ENEL-MED onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2024 | 680 | 7 | 45 | 88 | N/A |
| 3/31/2024 | 654 | 16 | 50 | 95 | N/A |
| 12/31/2023 | 619 | 8 | 48 | 81 | N/A |
| 9/30/2023 | 589 | 7 | 27 | 66 | N/A |
| 6/30/2023 | 542 | 7 | 20 | 64 | N/A |
| 3/31/2023 | 522 | -23 | 3 | 53 | N/A |
| 12/31/2022 | 495 | -24 | -6 | 40 | N/A |
| 9/30/2022 | 476 | -30 | -4 | 45 | N/A |
| 6/30/2022 | 476 | -27 | -3 | 46 | N/A |
| 3/31/2022 | 450 | -7 | 17 | 59 | N/A |
| 12/31/2021 | 441 | -1 | 29 | 67 | N/A |
| 9/30/2021 | 427 | -3 | 30 | 56 | N/A |
| 6/30/2021 | 419 | -1 | 41 | 58 | N/A |
| 3/31/2021 | 398 | 4 | 65 | 77 | N/A |
| 12/31/2020 | 400 | -3 | 63 | 74 | N/A |
| 9/30/2020 | 407 | 4 | 76 | 88 | N/A |
| 6/30/2020 | 410 | -1 | 77 | 90 | N/A |
| 3/31/2020 | 424 | -8 | 43 | 67 | N/A |
| 12/31/2019 | 418 | -2 | 45 | 75 | N/A |
| 9/30/2019 | 406 | -7 | 30 | 61 | N/A |
| 6/30/2019 | 393 | -1 | 7 | 40 | N/A |
| 3/31/2019 | 382 | -3 | 6 | 30 | N/A |
| 12/31/2018 | 372 | -1 | -5 | 15 | N/A |
| 9/30/2018 | 360 | -7 | -7 | 11 | N/A |
| 6/30/2018 | 350 | -9 | -2 | 20 | N/A |
| 3/31/2018 | 338 | -5 | N/A | 27 | N/A |
| 12/31/2017 | 324 | -3 | N/A | 24 | N/A |
| 9/30/2017 | 309 | 2 | N/A | 30 | N/A |
| 6/30/2017 | 296 | 4 | N/A | 26 | N/A |
| 3/31/2017 | 285 | 3 | N/A | 20 | N/A |
| 12/31/2016 | 274 | 2 | N/A | 17 | N/A |
| 9/30/2016 | 265 | 1 | N/A | 18 | N/A |
| 6/30/2016 | 254 | -1 | N/A | 12 | N/A |
| 3/31/2016 | 244 | -2 | N/A | 11 | N/A |
| 12/31/2015 | 235 | 1 | N/A | 16 | N/A |
| 9/30/2015 | 226 | 2 | N/A | 8 | N/A |
| 6/30/2015 | 219 | 4 | N/A | 11 | N/A |
| 3/31/2015 | 216 | 42 | N/A | 13 | N/A |
| 12/31/2014 | 214 | 42 | N/A | 12 | N/A |
| 9/30/2014 | 216 | 43 | N/A | 16 | N/A |
| 6/30/2014 | 218 | 42 | N/A | 21 | N/A |
| 3/31/2014 | 212 | 4 | N/A | 18 | N/A |
| 12/31/2013 | 207 | 2 | N/A | 18 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if ENE's forecast earnings growth is above the savings rate (3.9%).
Winst versus markt: Insufficient data to determine if ENE's earnings are forecast to grow faster than the Polish market
Hoge groeiwinsten: Insufficient data to determine if ENE's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if ENE's revenue is forecast to grow faster than the Polish market.
Hoge groei-inkomsten: Insufficient data to determine if ENE's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if ENE's Return on Equity is forecast to be high in 3 years time